Perceptive Advisors Llc - Apr 1, 2024 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
10%+ Owner
Signature
/s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member
Stock symbol
ALDX
Transactions as of
Apr 1, 2024
Transactions value $
$1,934,505
Form type
4
Date filed
4/3/2024, 05:22 PM
Previous filing
Feb 21, 2024
Next filing
Apr 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALDX Common Stock Purchase $27.2K +8.37K +0.1% $3.25 8.6M Apr 1, 2024 See Footnote F1, F4
transaction ALDX Common Stock Purchase $640K +186K +2.16% $3.44 8.79M Apr 2, 2024 See Footnote F2, F4
transaction ALDX Common Stock Purchase $1.27M +310K +3.53% $4.09 9.1M Apr 3, 2024 See Footnote F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.24 to $3.25 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.
F2 The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.245 to $3.55 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.
F3 The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.675 to $4.21 inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.
F4 The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.